Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China-Reference-Cited by-同舟云学术

Molecular epidemiology of bla OXA-23 -producing carbapenem-resistant Acinetobacter baumannii in a single institution over a 65-month period in north China

Published:2017-01-05 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Ning Nian-zhi,Liu Xiong,Bao Chun-mei,Chen Su-ming,Cui En-bo,zhang Ju-ling,Huang Jie,Chen Fang-hong,Li Tao,Qu Fen,Wang Hui

Funder

National Key Basic Research Program (973) of China

National Science and Technology Major Project for Creation of Major New Drugs of China

National Natural Science Foundation of China

State Key Laboratory of Pathogen and BioSecurity Program(CN)

State Key Research Development Program Of China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-2110-1.pdf

Reference48 articles.

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148–65.

2. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–84.

3. Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, Gomez-Lus R, Jimenez de Anta T. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 1993;37(1):138–41.

4. Seifert H, Stefanik D, Wisplinghoff H. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother. 2006;58(5):1099–100.

5. Evans BA, Hamouda A, Amyes SG. The rise of carbapenem-resistant Acinetobacter baumannii. Curr Pharm Des. 2013;19(2):223–38.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular epidemiology of Acinetobacter baumannii during COVID-19 at a hospital in northern China;Annals of Clinical Microbiology and Antimicrobials;2024-07-18

2. Seasonal meropenem resistance in Acinetobacter baumannii and influence of temperature-driven adaptation;BMC Microbiology;2024-04-27

3. EFFECT OF METHYLENE BLUE, EOSIN METHYLENE BLUE AGAR, AND COMBINATIONAL ANTIBIOTIC ON CARBAPENEM RESISTANCE OF ACINETOBACTER BAUMANNII VIA IN VITRO AND IN SILICO APPROACH;Applied Ecology and Environmental Research;2024

4. A global view on carbapenem-resistant Acinetobacter baumannii;mBio;2023-12-19

5. Molecular and virulence characteristics of carbapenem-resistant Acinetobacter baumannii isolates: a prospective cohort study;Scientific Reports;2023-11-09